WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹14 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹-32 Cr |
| Mar2022 | ₹-29 Cr |
| Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 85.50 | |
| Mar2024 | ₹14 Cr | Positive | |
| Mar2023 | ₹-32 Cr | Negative | |
| Mar2022 | ₹-29 Cr | Negative | |
| Mar2021 | ₹-17 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹1,041.4 Cr | -7.2% | 8.8% | 17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -7.2% |
8.8% |
17.4% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses